Advertisement

Topics

IntelliPharmaCeutics Corp. Company Profile

20:15 EDT 19th September 2018 | BioPortfolio


News Articles [88 Associated News Articles listed on BioPortfolio]

Intellipharmaceutics International Inc.: Intellipharmaceutics Announces Closing of US$3.5 Million Financing

TORONTO, ON / ACCESSWIRE / March 16, 2018 / Intellipharmaceutics International Inc. (NASDAQ: IPCI) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in th...

Intellipharmaceutics International Inc.: Intellipharmaceutics Announces Closing of US$1.8 Million Financing

TORONTO, ON / ACCESSWIRE / March 21, 2018 / Intellipharmaceutics International Inc. (NASDAQ: IPCI) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in th...

Intellipharmaceutics International Inc.: Intellipharmaceutics Reports Director Election Results

TORONTO, ON / ACCESSWIRE / May 16, 2018 / Intellipharmaceutics International Inc. (NASDAQ: IPCI; TSX: IPCI) ('Intellipharmaceutics' or the 'Company'), a pharmaceutical company specializing in the r...

Intellipharmaceutics International Inc.: Intellipharmaceutics Closes US$0.5 Million Convertible Debenture Financing

TORONTO, ON / ACCESSWIRE / September 11, 2018 / Intellipharmaceutics International Inc. (NASDAQ: IPCI; TSX: IPCI) ('Intellipharmaceutics' or the 'Company'), a pharmaceutical company specializing in...

Intellipharmaceutics International Inc.: Intellipharmaceutics Announces US$3.5 Million Registered Direct Offering

TORONTO, ON / ACCESSWIRE / March 14, 2018 / Intellipharmaceutics International Inc. (NASDAQ: IPCI) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in th...

Intellipharmaceutics International Inc.: Nasdaq Hearings Panel Grants Intellipharmaceutics' Request for Continued Listing

TORONTO, ON / ACCESSWIRE / May 22, 2018 / Intellipharmaceutics International Inc. (NASDAQ: IPCI and TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in th...

Korea Investment CORP Boosts Stake in Mylan

Korea Investment CORP grew its position in Mylan by 462.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 736,474 shar...

GTX Corp First Quarter 2018 Summary

Revenues increased 76%, Subscribers increased 79%, G&A decreased 17% LOS ANGELES, May 16, 2018 (GLOBE NEWSWIRE) -- GTX Corp. (OTCQB:GTXO), an IoT platform and leading provider of personal loc...

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules

The ex-vivo lung will be evaluated by XLTF-UC180 for localization of the tumor. The ultrasound probe will be put on the lung surface in several different directions to obtain the cross sec...

More Information about "IntelliPharmaCeutics Corp." on BioPortfolio

We have published hundreds of IntelliPharmaCeutics Corp. news stories on BioPortfolio along with dozens of IntelliPharmaCeutics Corp. Clinical Trials and PubMed Articles about IntelliPharmaCeutics Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of IntelliPharmaCeutics Corp. Companies in our database. You can also find out about relevant IntelliPharmaCeutics Corp. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record